Halozyme Therapeutics
HALO
New Fortress Energy
NFE
DexCom
DXCM
4
YETI Holdings
YETI
5
Teradata Corp
TDC
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -9.32%53.88M | 292.66%374.38M | 256.11%36.78M | 319.30%198.97M | 121.63%79.21M | 66.39%59.42M | -50.96%95.34M | -138.54%-23.56M | -7.42%47.45M | 17.95%35.74M |
Net income from continuing operations | 23.46%28.21M | 32.70%231.73M | 21.65%38.95M | 269.90%149.31M | -32.58%20.62M | -68.11%22.85M | 51.66%174.62M | -19.24%32.02M | 32.06%40.37M | 17.01%30.58M |
Operating gains losses | 61.23%-6.4M | -24.12%-44.15M | -8.46%-9.63M | 19.35%-9.86M | 26.85%-8.15M | -397.86%-16.5M | 5.40%-35.57M | 21.41%-8.88M | -17.88%-12.23M | -5.64%-11.14M |
Depreciation and amortization | -2.89%26.4M | -1.76%107.46M | -3.28%26.63M | -0.71%26.69M | -1.55%26.94M | -1.46%27.19M | -1.77%109.38M | -1.92%27.53M | -3.70%26.88M | -1.45%27.37M |
Deferred tax | -57.25%2.01M | 327.55%38.57M | -49.13%6.65M | 114.78%20.34M | 14.53%6.88M | 110.35%4.71M | -477.89%-16.95M | 48.73%13.07M | 524.54%9.47M | 380.97%6.01M |
Other non cash items | 1,050.00%23K | 100.11%66K | 2,900.00%60K | 0.00%2K | 100.08%2K | 100.00%2K | -384,506.25%-61.51M | -33.33%2K | -50.00%2K | -52,660.00%-2.63M |
Change In working capital | -96.10%730K | 134.27%29.31M | 68.31%-28.88M | 149.33%9.53M | 276.22%29.95M | -55.35%18.72M | -997.01%-85.53M | -1,115.16%-91.14M | -5,845.23%-19.32M | -34.72%-16.99M |
-Change in receivables | -33.41%10.1M | 116.24%6.14M | 147.14%4.73M | 71.02%-7.71M | 65.09%-6.05M | -6.44%15.17M | -20.46%-37.78M | -1,590.74%-10.04M | -16.29%-26.62M | -9.64%-17.33M |
-Change in inventory | 69.20%-2.81M | 243.90%1.12M | 560.13%7.98M | 28.70%5.93M | -186.10%-3.67M | -71.71%-9.12M | 87.13%-779K | --1.21M | --4.61M | ---1.28M |
-Change in prepaid assets | 107.13%10.97M | 124.13%6.89M | 43.40%-13.1M | 505.81%14.17M | 325.41%519K | 360.73%5.3M | -173.73%-28.55M | -436.21%-23.15M | 45.93%-3.49M | 100.81%122K |
-Change in payables and accrued expense | -532.25%-24.61M | 151.53%16.76M | 77.95%-14.41M | 3.74%7.85M | 693.91%27.21M | -113.04%-3.89M | -298.97%-32.53M | -3,428.78%-65.34M | -47.69%7.56M | -198.69%-4.58M |
-Change in other working capital | -37.22%7.07M | -111.30%-1.59M | -327.76%-14.09M | -674.17%-10.7M | 96.44%11.93M | 250.16%11.27M | -40.53%14.09M | 163.79%6.19M | -109.49%-1.38M | -55.39%6.07M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -9.32%53.88M | 292.66%374.38M | 256.11%36.78M | 319.30%198.97M | 121.63%79.21M | 66.39%59.42M | -50.96%95.34M | -138.54%-23.56M | -7.42%47.45M | 17.95%35.74M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 96.54%-2.7M | 77.15%-150.76M | 83.53%-9.94M | 77.88%-6.93M | -32.05%-55.77M | 85.15%-78.11M | -402.09%-659.88M | -35.15%-60.32M | -82.08%-31.34M | -20.52%-42.24M |
Net PPE purchase and sale | 96.54%-2.7M | 23.78%-150.76M | 83.45%-9.94M | 73.19%-6.93M | -41.14%-55.77M | -7.90%-78.11M | -50.50%-197.8M | -34.50%-60.03M | -50.26%-25.86M | -12.76%-39.52M |
Net business purchase and sale | ---- | --0 | --0 | --0 | ---- | ---- | ---462.08M | ---293K | ---5.48M | ---2.72M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 96.54%-2.7M | 61.53%-150.76M | 83.53%-9.94M | 77.88%-6.93M | -52.06%-55.77M | 70.36%-78.11M | -198.16%-391.87M | -35.15%-60.32M | -82.08%-31.34M | -4.66%-36.68M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -346.32%-48.59M | -175.46%-223.69M | -136.34%-30.09M | -1,105.04%-197.37M | -749.55%-15.95M | -91.33%19.73M | 566.59%296.44M | 584.14%82.81M | 50.69%-16.38M | -36.73%2.46M |
Net issuance payments of debt | -186.82%-30.89M | -149.41%-172.56M | -119.03%-18.14M | -3,619.45%-185.71M | -130.98%-4.29M | -85.48%35.58M | 2,844.40%349.23M | 1,765.21%95.33M | 77.30%-4.99M | -20.76%13.85M |
Cash dividends paid | -2.63%-12.08M | -2.64%-46.76M | -2.41%-11.66M | -2.42%-11.66M | -2.45%-11.66M | -3.28%-11.77M | -2.91%-45.56M | -2.65%-11.39M | -2.65%-11.39M | -2.75%-11.38M |
Net other financing activities | -37.58%-5.62M | 39.57%-4.37M | 74.49%-289K | --0 | --0 | 32.93%-4.08M | -10.61%-7.23M | -296.15%-1.13M | --0 | 99.45%-14K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -346.32%-48.59M | -175.46%-223.69M | -136.34%-30.09M | -1,105.04%-197.37M | -749.55%-15.95M | -91.33%19.73M | 566.59%296.44M | 584.14%82.81M | 50.69%-16.38M | -36.73%2.46M |
Net cash flow | ||||||||||
Beginning cash position | -7.98%807K | -8.36%877K | 108.43%4.06M | 326.12%9.4M | 177.10%1.91M | -8.36%877K | -35.81%957K | 24.66%1.95M | 152.29%2.21M | -56.96%690K |
Current changes in cash | 149.76%2.59M | 21.35%-70K | -203.93%-3.25M | -1,900.00%-5.34M | 393.02%7.48M | 481.92%1.04M | 83.14%-89K | -77.57%-1.07M | -132.32%-267K | 275.90%1.52M |
Effect of exchange rate changes | ---- | --0 | --0 | --0 | ---- | ---- | 250.00%9K | --0 | 105.76%8K | -102.24%-3K |
End cash Position | 77.41%3.39M | -7.98%807K | -7.98%807K | 108.43%4.06M | 326.12%9.4M | 177.10%1.91M | -8.36%877K | -8.36%877K | 24.66%1.95M | 152.29%2.21M |
Free cash flow | 186.20%38.36M | 180.14%142.92M | 107.91%8.66M | 17,192.71%171.1M | 140.32%7.66M | 8.96%-44.5M | -1,539.92%-178.33M | -3,338.83%-109.46M | -108.57%-1M | 27.71%-18.99M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | -- |